用各种-18标记假肢组标记的纳米基PET标记物的脏比较摄入量

Colleen P Olkowski1, Falguni Basuli2, Bruna Fernandes1

  • 1Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States.

Molecular pharmaceutics
|December 16, 2024
PubMed
概括

优化纳米体放射性药物:用-18标记的金假体组显著减少脏保留,并增强瘤向,以改善分子成像和治疗.